IQE shares rise 4% as AI, data center demand lifts first-half revenue

IQE reported first-half revenue growth of 43% year-on-year to £64.6 million and adjusted EBITDA of £6.0 million, reversing a £0.4 million loss a year earlier. Photonics revenue rose 45% to £38.5 million on AI, data-centre and U.S. defense-program demand, while wireless revenue increased 40% to £26.0 million. The company said trading exceeded expectations, maintained its forecast for more than 30% revenue growth in 2026, and plans to expand Indium Phosphide capacity; shares rose 4.11% in early London trading.

Analysis

IQE’s relevance is less as a direct AI beneficiary than as an upstream bottleneck candidate in indium-phosphide epitaxy, where qualification cycles are long and supply substitution is difficult. If the new capacity is absorbed under its recently signed agreements, incremental revenue should carry disproportionately high conversion to EBITDA because fixed fab costs have already been reset against higher utilization. The second-order read-through is constructive for optical-component vendors COHR, LITE and MTSI, but IQE’s improving mix could also signal that supply-chain value is shifting upstream from transceiver assemblers toward scarce compound-semiconductor materials.

The immediate equity move is unlikely to fully capitalize a durable earnings inflection if management can demonstrate that demand is backed by binding volume commitments rather than customer inventory positioning. The key 1-3 month catalyst is evidence of order visibility and capacity ramp execution; the 6-18 month issue is whether AI optical architectures sustain indium-phosphide content growth rather than migrating toward lower-cost silicon photonics solutions. This remains a high-risk small-cap execution story: capacity additions can consume cash before revenue conversion, and low customer concentration or a delayed hyperscaler capex cycle would sharply impair the operating-leverage thesis.

Consensus may be treating this as another generic AI narrative, while the more important question is whether IQE has crossed the utilization threshold that makes its manufacturing footprint structurally profitable. Conversely, the headline growth rate should not be extrapolated without bookings, customer concentration, gross-margin and net-debt data. A failure to translate the ramp into rising gross margin and operating cash flow by the next full reporting cycle would indicate that the recovery is mix- or timing-driven rather than a durable rerating event.

Key Decisions for Investors

• Establish only a starter long in IQE.L after confirming liquidity and current valuation versus the low-teens EBITDA outlook; add on evidence that second-half capacity is qualified and customer orders extend into 2027. Target a 6-12 month holding period, with the thesis invalidated by reduced growth guidance, a margin reversal, or material incremental funding needs.
• Use COHR or LITE as a more liquid read-through long over the next 1-3 months if optical networking order commentary confirms broad-based hyperscaler demand; avoid treating IQE’s result alone as sufficient confirmation because its customer and product mix may be idiosyncratic.
• Watch IQE’s next disclosure for backlog/contract duration, cash burn, capex requirements and top-customer exposure before sizing beyond a tactical position. Missing visibility on these variables makes a leveraged or options expression inappropriate.
• For a relative-value implementation, consider long IQE.L versus short a broad UK technology proxy only after the initial reaction stabilizes; the intended exposure is to company-specific utilization and optical-material scarcity, not to FTSE risk sentiment. Exit if the relative move is driven solely by AI multiple expansion without corroborating order and cash-flow data.